Heparin-Induced Thrombocytopenia in Intensive Care PatientsSELLENG, Kathleen; SELLENG, Sixten; GREINACHER, Andreas et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 5, pp 425-438, issn 0094-6176, 14 p.Article

The management of heparin-induced thrombocytopeniaKEELING, David; DAVIDSON, Simon; WATSON, Henry et al.British journal of haematology. 2006, Vol 133, Num 3, pp 259-269, issn 0007-1048, 11 p.Article

Heparin-induced thrombocytopenia in childrenNEWALL, F; BARNES, C; IGNJATOVIC, V et al.Journal of paediatrics and child health. 2003, Vol 39, Num 4, pp 289-292, issn 1034-4810, 4 p.Article

Current and Emerging Therapeutics for Heparin-Induced ThrombocytopeniaCUKER, Adam.Seminars in thrombosis and hemostasis. 2012, Vol 38, Num 1, pp 31-37, issn 0094-6176, 7 p.Article

Heparin-induced thrombocytopenia : What clinicians need to knowCHONG, Beng H; ISAACS, Arend.Thrombosis and haemostasis. 2009, Vol 101, Num 2, pp 279-283, issn 0340-6245, 5 p.Article

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literatureKLENNER, Anne F; LUBENOW, Norbert; RASCHKE, Ricarda et al.Thrombosis and haemostasis. 2004, Vol 91, Num 4, pp 719-724, issn 0340-6245, 6 p.Article

Heparin-Dependent Antibodies and Thrombosis without Heparin-Induced ThrombocytopeniaBREAM-ROUWENHORST, Heather R; HOBBS, Ryan A.Pharmacotherapy. 2008, Vol 28, Num 11, pp 1401-1407, issn 0277-0008, 7 p.Article

Endothelial cell damage in heparin-induced thrombocytopeniaDAVIDSON, Simon J; WADHAM, Paul; ROGERS, Louise et al.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 4, pp 317-320, issn 0957-5235, 4 p.Article

Heparin-induced thrombocytopenia : A reviewGIROLAMI, Bruno; GIROLAMI, Antonio.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 8, pp 803-809, issn 0094-6176, 7 p.Article

Update on heparin-induced thrombocytopenia and cardiovascular interventionsSPIESS, Bruce D.Seminars in hematology. 2005, Vol 42, Num 3, pp S22-S27, issn 0037-1963, SUP3Conference Paper

Current developments in antithrombotic therapy: The role of antithrombin agentsBREDDIN, H. K.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 1-8, issn 1424-8832, 8 p., SUP3Conference Paper

Weight-Based Argatroban Dosing Nomogram for Treatment of Heparin-Induced Thrombocytopenia. CommentaryANSARA, Alexander J; ARIF, Sally; WARHURST, Robert D et al.The Annals of pharmacotherapy. 2009, Vol 43, Num 1, issn 1060-0280, 9-18, 114-117 [14 p.]Article

A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinGERDSEN, Frank; LUXEMBOURG, Beate; LANGER, Florian et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 6, pp 477-481, issn 0957-5235, 5 p.Article

Bivalirudin for Patients with Heparin-lnduced Thrombocytopenia Undergoing Cardiovascular SurgeryCZOSNOWSKI, Quinn A; FINKS, Shannon W; ROGERS, Kelly C et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 9, pp 1304-1309, issn 1060-0280, 6 p.Article

Platelet PI^A2 Polymorphism and the Risk for Thrombosis in Heparin-lnduced ThrombocytopeniaHARRIS, Kenneth; NGUYEN, Phan; VAN COTT, Elizabeth M et al.American journal of clinical pathology. 2008, Vol 129, Num 2, pp 282-286, issn 0002-9173, 5 p.Article

Argatroban for Percutaneous Coronary InterventionsIQBAL, Omer; ADIGUZEL, Cafer; LEWIS, Bruce E et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 62-74, issn 0094-6176, 13 p., SUP1Article

The Anti-Inflammatory Effects of Argatroban Can Be Differentiated from Other Direct Thrombin Inhibitors : Experimental and Clinical ObservationsHOPPENSTEADT, Debra A; JESKE, Walter; WALENGA, Jeanine M et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 97-102, issn 0094-6176, 6 p., SUP1Article

Okamoto's Strategy to Develop Argatroban : An Innovative Concept for the FutureIKEDA, Yasuo; WANAKA, Keiko; OKAMOTO, Utako et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 7-11, issn 0094-6176, 5 p., SUP1Article

Mechanisms Involved in Heparin-Induced Thrombocytopenia and Associated ThrombosisVISSAC, Anne Marie; AMIRAL, Jean.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 18-26, issn 0094-6176, 9 p., SUP1Article

Argatroban anticoagulation in critically III patientsBEIDERLINDEN, Martin; TRESCHAN, Tanja A; GÖRLINGER, Klaus et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 5, pp 749-754, issn 1060-0280, 6 p.Article

Treatment of heparin-induced thrombocytopenia : Is there a role for bivalirudin?SEYBERT, Amy L; COONS, James C; ZERUMSKY, Kristin et al.Pharmacotherapy. 2006, Vol 26, Num 2, pp 229-241, issn 0277-0008, 13 p.Article

Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysisMURRAY, Patrick T; HURSTING, Marcie J.Renal failure. 2006, Vol 28, Num 7, pp 537-539, issn 0886-022X, 3 p.Article

Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients : Safety of resuming heparin after disappearance of HIT antibodies. CommentaryHARTMAN, V; MALBRAIN, M; DAELEMANS, R et al.The Nephron journals. 2006, Vol 104, Num 4, issn 1660-8151, c143-c150Article

Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis : A retrospective analysis of 408 patientsGREINACHER, Andreas; FARNER, Beate; KROLL, Hartmut et al.Thrombosis and haemostasis. 2005, Vol 94, Num 1, pp 132-135, issn 0340-6245, 4 p.Article

Heparin-Induced Thrombocytopenia Clinical Studies and the Efficacy of Argatroban in JapanMIYATA, Shigeki; YAMAMOTO, Haruko; KAMEI, Masataka et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 37-47, issn 0094-6176, 11 p., SUP1Article